Helminth-derived molecules: Pathogenic and pharmacopeial roles

Abstract

Parasitic helminths, taxonomically comprising trematodes, cestodes, and nematodes, are multicellular invertebrates widely disseminated in nature and have afflicted humans continuously for a long time. Helminths play potent roles in the host by generating a variety of novel molecules, including some excretory/secretory products and others that are involved in intracellular material exchange and information transfer as well as the initiation or stimulation of immune and metabolic activation. The helminth-derived molecules have developed powerful and diverse immunosuppressive effects to achieve immune evasion for parasite survival and establish chronic infections. However, they also improve autoimmune and allergic inflammatory responses and promote metabolic homeostasis by promoting metabolic reprogramming of various immune functions, and then inducing alternatively activated macrophages, T helper 2 cells, and regulatory T cell-mediated immune responses. Therefore, a deeper exploration of the immunopathogenic mechanism and immune regulatory mechanisms of helminth-derived molecules exerted in the host is crucial for understanding host-helminth interactions, as well as the development of therapeutic drugs for infectious or non-infectious diseases. In this review, we focus on the properties of helminth-derived molecules to give an overview of the most recent scientific knowledge about their pathogenic and pharmacopeial roles in immune-metabolic homeostasis.

Keywords

helminth / helminth-derived molecules / immunity / metabolism / excretory/secretory products / extracellular vesicles

Fundings

This work was supported by the National Natural Science Foundation of China (Z.P.X, Grant No. 82472311), the Natural Science Foundation of Jiangsu Province (Z.P.X, Grant No. BK20211586), the Funding of the State Key Laboratory of Reproductive Medicine (Z.P.X, Grant Nos. SKLRM-2021C3 and SKLRM-2024B14), the Medical Scientific Research Project of Jiangsu Provincial Health Commission (Z.P.X, Grant No. Z2021004), the National Sharing Service Platform for Parasite Resources (Z.P.X, Grant No. TDRC-2019-194-30), and the Qing Lan Project of Jiangsu Province of China (Z.P.X, Grant No. KY101R202127). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Acknowledgments

None.

References

[1] Rovira-Diaz E, El-Naccache DW, Reyes J, et al. The impact of helminth coinfection on innate and adaptive immune resistance and disease tolerance during toxoplasmosis[J]. J Immunol, 2022, 209(11): 2160-2171. doi: 10.4049/jimmunol.2200504

[2] Peng J, Federman HG, Hernandez CM, et al. Communication is key: innate immune cells regulate host protection to helminths[J]. Front Immunol, 2022, 13: 995432. doi: 10.3389/fimmu.2022.995432

[3] Harris NL, Loke P. Recent advances in type-2-cell-mediated immunity: insights from helminth infection[J]. Immunity, 2017, 47(6): 1024-1036. doi: 10.1016/j.immuni.2017.11.015

[4] Chen J, Zhou J, Pan W. Immunometabolism: towards a better understanding the mechanism of parasitic infection and immunity[J]. Front Immunol, 2021, 12: 661241. doi: 10.3389/fimmu.2021.661241

[5] Wammes LJ, Mpairwe H, Elliott AM, et al. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations[J]. Lancet Infect Dis, 2014, 14(11): 1150-1162. doi: 10.1016/S1473-3099(14)70771-6

[6] Siles-Lucas M, González-Miguel J, Geller R, et al. Potential influence of helminth molecules on COVID-19 pathology[J]. Trends Parasitol, 2021, 37(1): 11-14. doi: 10.1016/j.pt.2020.10.002

[7] Hardisty GR, Knipper JA, Fulton A, et al. Concurrent infection with the filarial helminth Litomosoides sigmodontis attenuates or worsens influenza a virus pathogenesis in a stage-dependent manner[J]. Front Immunol, 2022, 12: 819560. doi: 10.3389/fimmu.2021.819560

[8] Bradbury RS, Piedrafita D, Greenhill A, et al. Will helminth co-infection modulate COVID-19 severity in endemic regions?[J]. Nat Rev Immunol, 2020, 20(6): 342. doi: 10.1038/s41577-020-0330-5

[9] Sobotková K, Parker W, Levá J, et al. Helminth therapy - from the parasite perspective[J]. Trends Parasitol, 2019, 35(7): 501-515. doi: 10.1016/j.pt.2019.04.009

[10] Leonardi-Bee J, Pritchard D, Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis[J]. Am J Respir Crit Care Med, 2006, 174(5): 514-523. doi: 10.1164/rccm.200603-331OC

[11] Fernandes JS, Cardoso LS, Pitrez PM, et al. Helminths and asthma: risk and protection[J]. Immunol Allergy Clin North Am, 2019, 39(3): 417-427. doi: 10.1016/j.iac.2019.03.009

[12] Maizels RM, Smits HH, McSorley HJ. Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules[J]. Immunity, 2018, 49(5): 801-818. doi: 10.1016/j.immuni.2018.10.016

[13] Sánchez-López CM, Trelis M, Bernal D, et al. Overview of the interaction of helminth extracellular vesicles with the host and their potential functions and biological applications[J]. Mol Immunol, 2021, 134: 228-235. doi: 10.1016/j.molimm.2021.03.020

[14] Yeshi K, Ruscher R, Loukas A, et al. Immunomodulatory and biological properties of helminth-derived small molecules: potential applications in diagnostics and therapeutics[J]. Front Parasitol, 2022, 1: 984152. doi: 10.3389/fpara.2022.984152

[15] Sanya RE, Nkurunungi G, Biraro IA, et al. A life without worms[J]. Trans R Soc Trop Med Hyg, 2017, 111(1): 3-11. doi: 10.1093/trstmh/trx010

[16] Aranzamendi C, Sofronic-Milosavljevic L, Pinelli E. Helminths: immunoregulation and inflammatory diseases-which side are Trichinella spp. and Toxocara spp. on?[J]. J Parasitol Res, 2013, 2013: 329438. https://preview.hindawi.com/journals/jpr/2013/329438/

[17] Wu Z, Wang L, Li J, et al. Extracellular vesicle-mediated communication within host-parasite interactions[J]. Front Immunol, 2018, 9: 3066. doi: 10.3389/fimmu.2018.03066/full

[18] Trelis M, Sánchez-López CM, Sánchez-Palencia LF, et al. Proteomic analysis of extracellular vesicles from Fasciola hepatica hatching eggs and juveniles in culture[J]. Front Cell Infect Microbiol, 2022, 12: 903602. doi: 10.3389/fcimb.2022.903602

[19] Li S, Giri BR, Liu J, et al. Characterization of MicroRNA cargo of extracellular vesicles isolated from the plasma of Schistosoma japonicum-infected mice[J]. Front Cell Infect Microbiol, 2022, 12: 803242. doi: 10.3389/fcimb.2022.803242

[20] Ovchinnikov VY, Kashina EV, Mordvinov VA, et al. EV-transported microRNAs of Schistosoma mansoni and Fasciola hepatica: potential targets in definitive hosts[J]. Infect Genet Evol, 2020, 85: 104528. doi: 10.1016/j.meegid.2020.104528

[21] Drurey C, Coakley G, Maizels RM. Extracellular vesicles: new targets for vaccines against helminth parasites[J]. Int J Parasitol, 2020, 50(9): 623-633. doi: 10.1016/j.ijpara.2020.04.011

[22] Knox DP. Proteinase inhibitors and helminth parasite infection[J]. Parasite Immunol, 2007, 29(2): 57-71. doi: 10.1111/j.1365-3024.2006.00913.x

[23] Zhu B, Luo F, Shen Y, et al. Schistosoma japonicum cathepsin B2 (SjCB2) facilitates parasite invasion through the skin[J]. PLoS Negl Trop Dis, 2020, 14(10): e0008810. doi: 10.1371/journal.pntd.0008810

[24] Xie H, Wu L, Chen X, et al. Schistosoma japonicum cystatin alleviates sepsis through activating regulatory macrophages[J]. Front Cell Infect Microbiol, 2021, 11: 617461. doi: 10.3389/fcimb.2021.617461

[25] Gao S, Li H, Xie H, et al. Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model[J]. Parasit Vectors, 2020, 13(1): 260. doi: 10.1186/s13071-020-04104-3

[26] Xue Y, Yang X, Zhang H, et al. Protective effect of recombinant Schistosoma japonicum cystatin against acute kidney injury associated with acute liver failure in mice[J]. Chin J Schistosomiasis Control, 2023, 35(4): 331-339. https://www.zgxfzz.com/CN/Y2023/V35/I4/331 (in Chinese)

[27] Yang H, Li H, Chen W, et al. Therapeutic effect of Schistosoma japonicum cystatin on atherosclerotic renal damage[J]. Front Cell Dev Biol, 2021, 9: 760980. doi: 10.3389/fcell.2021.760980

[28] Chen Y, Wei B, Xu P, et al. Schistosoma japonicum cystatin suppresses osteoclastogenesis via manipulating the NF-κB signaling pathway[J]. Mol Med Rep, 2021, 23(4): 273. doi: 10.3892/mmr.2021.11912

[29] Owen CA, Campbell EJ. The cell biology of leukocyte-mediated proteolysis[J]. J Leukoc Biol, 1999, 65(2): 137-150. doi: 10.1002/jlb.65.2.137

[30] Morais SB, Figueiredo BC, Assis NRG, et al. Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation[J]. PLoS Pathog, 2018, 14(2): e1006870. doi: 10.1371/journal.ppat.1006870

[31] Ranasinghe SL, Duke M, Harvie M, et al. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni[J]. Int J Infect Dis, 2018, 66: 26-32. doi: 10.1016/j.ijid.2017.10.024

[32] Perbandt M, Ndjonka D, Liebau E. Protective mechanisms of helminths against reactive oxygen species are highly promising drug targets[J]. Curr Med Chem, 2014, 21(15): 1794-1808. doi: 10.2174/0929867320666131119122907

[33] Han Y, Zhao B, Zhang M, et al. Biochemical properties and vaccine effect of recombinant TPx-3 from Schistosoma japonicum[J]. Parasitol Res, 2017, 116(4): 1361-1372. doi: 10.1007/s00436-017-5415-0

[34] Cao X, Fu Z, Zhang M, et al. iTRAQ-based comparative proteomic analysis of excretory-secretory proteins of schistosomula and adult worms of Schistosoma japonicum[J]. J Proteomics, 2016, 138: 30-39. doi: 10.1016/j.jprot.2016.02.015

[35] Xu Z, Ji M, Li C, et al. A Biological and immunological characterization of Schistosoma japonicum heat shock proteins 40 and 90α[J]. Int J Mol Sci, 2020, 21(11): 4034. doi: 10.3390/ijms21114034

[36] Ni Y, Xu Z, Li C, et al. Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism[J]. Theranostics, 2021, 11(3): 1079-1099. doi: 10.7150/thno.49354

[37] Zhou S, Qi Q, Wang X, et al. SjHSP60 induces CD4⁺CD25⁺Foxp3⁺ Tregs via TLR4-Mal-drived production of TGF-β in macrophages[J]. Immunol Cell Biol, 2018, 96(9): 958-968. doi: 10.1111/imcb.12160

[38] Shan W, Zhang W, Xue F, et al. Schistosoma japonicum peptide SJMHE1 inhibits acute and chronic colitis induced by dextran sulfate sodium in mice[J]. Parasit Vectors, 2021, 14(1): 455. doi: 10.1186/s13071-021-04977-y

[39] Wang X, Wang J, Liang Y, et al. Schistosoma japonicum HSP60-derived peptide SJMHE1 suppresses delayed-type hypersensitivity in a murine model[J]. Parasit Vectors, 2016, 9: 147. doi: 10.1186/s13071-016-1434-4

[40] Wang X, Li L, Wang J, et al. Inhibition of cytokine response to TLR stimulation and alleviation of collagen-induced arthritis in mice by Schistosoma japonicum peptide SJMHE1[J]. J Cell Mol Med, 2017, 21(3): 475-486. doi: 10.1111/jcmm.12991

[41] Wang L, Xie H, Xu L, et al. rSj16 protects against DSS-induced colitis by inhibiting the PPAR-α signaling pathway[J]. Theranostics, 2017, 7(14): 3446-3460. doi: 10.7150/thno.20359

[42] Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis[J]. Adv Drug Deliv Rev, 2017, 121: 27-42. doi: 10.1016/j.addr.2017.05.007

[43] Dewidar B, Meyer C, Dooley S, et al. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11): 1419. doi: 10.3390/cells8111419

[44] Sun X, Zhang L, Wang J, et al. Schistosoma japonicum protein SjP40 inhibits TGF-β1-induced activation of hepatic stellate cells[J]. Parasitol Res, 2015, 114(11): 4251-4257. doi: 10.1007/s00436-015-4663-0

[45] Li J, Zhang J, Zhang B, et al. rSjP40 inhibited the activity of collagen type I promoter via Ets-1 in HSCs[J]. Front Cell Dev Biol, 2021, 9: 765616. doi: 10.3389/fcell.2021.765616

[46] Carson JP, Robinson MW, Ramm GA, et al. Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells[J]. Exp Parasitol, 2022, 236-237: 108255.

[47] Alizadeh Z, Mahami-Oskouei M, Spotin A, et al. MicroRNAs in helminth parasites: a systematic review[J]. Curr Mol Med, 2022, 22(9): 779-808. doi: 10.2174/1566524021666211108114009

[48] He X, Wang Y, Fan X, et al. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor Ⅲ[J]. J Hepatol, 2020, 72(3): 519-527. doi: 10.1016/j.jhep.2019.10.029

[49] Wang Q, Chou X, Guan F, et al. Enhanced Wnt Signalling in hepatocytes is associated with Schistosoma japonicum infection and contributes to liver fibrosis[J]. Sci Rep, 2017, 7(1): 230. doi: 10.1038/s41598-017-00377-4

[50] Wang Y, Fan X, Lei N, et al. A MicroRNA derived from Schistosoma japonicum promotes schistosomiasis hepatic fibrosis by targeting host secreted frizzled-related protein 1[J]. Front Cell Infect Microbiol, 2020, 10: 101. doi: 10.3389/fcimb.2020.00101

[51] Hu C, Zhu S, Wang J, et al. Schistosoma japonicum MiRNA-7-5p inhibits the growth and migration of hepatoma cells via cross-species regulation of S-phase kinase-associated protein 2[J]. Front Oncol, 2019, 9: 175. doi: 10.3389/fonc.2019.00175

[52] Liu J, Zhu L, Wang J, et al. Schistosoma japonicum extracellular vesicle miRNA cargo regulates host macrophage functions facilitating parasitism[J]. PLoS Pathog, 2019, 15(6): e1007817. doi: 10.1371/journal.ppat.1007817

[53] Wang Y, Gong W, Zhou H, et al. A novel miRNA from egg-derived exosomes of Schistosoma japonicum promotes liver fibrosis in murine schistosomiasis[J]. Front Immunol, 2022, 13: 860807. doi: 10.3389/fimmu.2022.860807

[54] Wang L, Liao Y, Yang R, et al. Sja-miR-71a in Schistosome egg-derived extracellular vesicles suppresses liver fibrosis caused by schistosomiasis via targeting semaphorin 4D[J]. J Extracell Vesicles, 2020, 9(1): 1785738. doi: 10.1080/20013078.2020.1785738

[55] Lin Y, Zhu S, Hu C, et al. Cross-species suppression of hepatoma cell growth and migration by a Schistosoma japonicum MicroRNA[J]. Mol Ther Nucleic Acids, 2019, 18: 400-412. doi: 10.1016/j.omtn.2019.09.006

[56] Meningher T, Barsheshet Y, Ofir-Birin Y, et al. Schistosomal extracellular vesicle-enclosed miRNAs modulate host T helper cell differentiation[J]. EMBO Rep, 2020, 21(1): e47882. doi: 10.15252/embr.201947882

[57] van Die I, van Vliet SJ, Nyame AK, et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x[J]. Glycobiology, 2003, 13(6): 471-478. doi: 10.1093/glycob/cwg052

[58] Kuipers ME, Nolte-'t Hoen ENM, van der Ham AJ, et al. DC-SIGN mediated internalisation of glycosylated extracellular vesicles from Schistosoma mansoni increases activation of monocyte-derived dendritic cells[J]. J Extracell Vesicles, 2020, 9(1): 1753420. doi: 10.1080/20013078.2020.1753420

[59] Dagenais M, Gerlach JQ, Wendt GR, et al. Analysis of Schistosoma mansoni extracellular vesicles surface glycans reveals potential immune evasion mechanism and new insights on their origins of biogenesis[J]. Pathogens, 2021, 10(11): 1401. doi: 10.3390/pathogens10111401

[60] Dagenais M, Gerlach JQ, Geary TG, et al. Sugar coating: utilisation of host serum sialoglycoproteins by Schistosoma mansoni as a potential immune evasion mechanism[J]. Pathogens, 2022, 11(4): 426. doi: 10.3390/pathogens11040426

[61] Bexkens ML, van Gestel RA, van Breukelen B, et al. Schistosoma mansoni infection affects the proteome and lipidome of circulating extracellular vesicles in the host[J]. Mol Biochem Parasitol, 2020, 238: 111296. doi: 10.1016/j.molbiopara.2020.111296

[62] Xu Z, Xu L, Li W, et al. Innate scavenger receptor-A regulates adaptive T helper cell responses to pathogen infection[J]. Nat Commun, 2017, 8: 16035. doi: 10.1038/ncomms16035

[63] Maestas Jr DR, Chung L, Han J, et al. Helminth egg derivatives as proregenerative immunotherapies[J]. Proc Natl Acad Sci U S A, 2023, 120(8): e2211703120. doi: 10.1073/pnas.2211703120

[64] Jiang J, Li J, Zhang Y, et al. The protective effect of the soluble egg antigen of Schistosoma japonicum in a mouse skin transplantation model[J]. Front Immunol, 2022, 13: 884006. doi: 10.3389/fimmu.2022.884006

[65] Tang C, Yu X, Li Y, et al. Schistosoma japonicum soluble egg antigen protects against type 2 diabetes in Lepr ^db/db mice by enhancing regulatory T cells and Th2 cytokines[J]. Front Immunol, 2019, 10: 1471. doi: 10.3389/fimmu.2019.01471

[66] Zaccone P, Burton OT, Gibbs S, et al. Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems[J]. J Biomed Biotechnol, 2010, 2010: 795210. https://pubmed.ncbi.nlm.nih.gov/20204176/

[67] Hou X, Zhu F, Zheng W, et al. Protective effect of Schistosoma japonicum eggs on TNBS-induced colitis is associated with regulating Treg/Th17 balance and reprogramming glycolipid metabolism in mice[J]. Front Cell Infect Microbiol, 2022, 12: 1028899. doi: 10.3389/fcimb.2022.1028899

[68] Li Z, Wang X, Zhang W, et al. Excretory/secretory products from Schistosoma japonicum eggs alleviate ovalbumin-induced allergic airway inflammation[J]. PLoS Negl Trop Dis, 2023, 17(10): e0011625. doi: 10.1371/journal.pntd.0011625

[69] Zhao L, Shi M, Zhou L, et al. Clonorchis sinensis adult-derived proteins elicit Th2 immune responses by regulating dendritic cells via mannose receptor[J]. PLoS Negl Trop Dis, 2018, 12(3): e0006251. doi: 10.1371/journal.pntd.0006251

[70] Celias DP, Corvo I, Silvane L, et al. Cathepsin L3 from Fasciola hepatica induces NLRP3 inflammasome alternative activation in murine dendritic cells[J]. Front Immunol, 2019, 10: 552. doi: 10.3389/fimmu.2019.00552

[71] De Marco Verissimo C, Jewhurst HL, Tikhonova IG, et al. Fasciola hepatica serine protease inhibitor family (serpins): purposely crafted for regulating host proteases[J]. PLoS Negl Trop Dis, 2020, 14(8): e0008510. doi: 10.1371/journal.pntd.0008510

[72] Falcón CR, Masih D, Gatti G, et al. Fasciola hepatica Kunitz type molecule decreases dendritic cell activation and their ability to induce inflammatory responses[J]. PLoS One, 2014, 9(12): e114505. doi: 10.1371/journal.pone.0114505

[73] Zhang K, Liu Y, Zhang G, et al. Molecular characteristics and potent immunomodulatory activity of Fasciola hepatica cystatin[J]. Korean J Parasitol, 2022, 60(2): 117-126. doi: 10.3347/kjp.2022.60.2.117

[74] Cwiklinski K, Drysdale O, Corrales JL, et al. Targeting secreted protease/anti-protease balance as a vaccine strategy against the helminth Fasciola hepatica[J]. Vaccines (Basel), 2022, 10(2): 155. doi: 10.3390/vaccines10020155

[75] Cwiklinski K, Robinson MW, Donnelly S, et al. Complementary transcriptomic and proteomic analyses reveal the cellular and molecular processes that drive growth and development of Fasciola hepatica in the host liver[J]. BMC Genomics, 2021, 22(1): 46. doi: 10.1186/s12864-020-07326-y

[76] Aguayo V, Fernandez BNV, Rodríguez-Valentín M, et al. Fasciola hepatica GST downregulates NF-κB pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model[J]. Sci Rep, 2019, 9(1): 2275. doi: 10.1038/s41598-018-37652-x

[77] Corral-Ruiz GM, Sánchez-Torres LE. Fasciola hepatica-derived molecules as potential immunomodulators[J]. Acta Trop, 2020, 210: 105548. doi: 10.1016/j.actatropica.2020.105548

[78] Wang X, Zhao C, Zhang G, et al. Molecular characterization of a novel GSTO2 of Fasciola hepatica and its roles in modulating murine macrophages[J]. Parasite, 2022, 29: 16. doi: 10.1051/parasite/2022016

[79] Yan C, Wang Y, Yu Q, et al. Clonorchis sinensis excretory/secretory products promote the secretion of TNF-alpha in the mouse intrahepatic biliary epithelial cells via Toll-like receptor 4[J]. Parasit Vectors, 2015, 8: 559. doi: 10.1186/s13071-015-1171-0

[80] Chung EJ, Jeong YI, Lee MR, et al. Heat shock proteins 70 and 90 from Clonorchis sinensis induce Th1 response and stimulate antibody production[J]. Parasit Vectors, 2017, 10(1): 118. doi: 10.1186/s13071-017-2026-7

[81] Bai X, Song JH, Dai F, et al. Clonorchis sinensis secretory protein CsAg17 vaccine induces immune protection[J]. Parasit Vectors, 2020, 13(1): 215. doi: 10.1186/s13071-020-04083-5

[82] Camaya I, Mok TY, Lund M, et al. The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells[J]. J Mol Med (Berl), 2021, 99(11): 1605-1621. doi: 10.1007/s00109-021-02122-x

[83] Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes[J]. J Diabetes, 2022, 14(4): 247-260. doi: 10.1111/1753-0407.13252

[84] Yan C, Zhou Q, Wu J, et al. Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries[J]. Proc Natl Acad Sci U S A, 2021, 118(46): e2102206118. doi: 10.1073/pnas.2102206118

[85] Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31(2): 107-125. doi: 10.1038/s41422-020-00441-1

[86] Wen L, Yin J, Wang Y, et al. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis[J]. Parasit Vectors, 2023, 16(1): 465. doi: 10.1186/s13071-023-06075-7

[87] Chaiyadet S, Sotillo J, Smout M, et al. Carcinogenic liver fluke secretes extracellular vesicles that promote cholangiocytes to adopt a tumorigenic phenotype[J]. J Infect Dis, 2015, 212(10): 1636-1645. doi: 10.1093/infdis/jiv291

[88] Chaiyadet S, Sotillo J, Krueajampa W, et al. Vaccination of hamsters with Opisthorchis viverrini extracellular vesicles and vesicle-derived recombinant tetraspanins induces antibodies that block vesicle uptake by cholangiocytes and reduce parasite burden after challenge infection[J]. PLoS Negl Trop Dis, 2019, 13(5): e0007450. doi: 10.1371/journal.pntd.0007450

[89] Phumrattanaprapin W, Pearson M, Pickering D, et al. Monoclonal antibodies targeting an Opisthorchis viverrini extracellular vesicle tetraspanin protect hamsters against challenge infection[J]. Vaccines (Basel), 2021, 9(7): 740. doi: 10.3390/vaccines9070740

[90] Li B, Yan C, Wu J, et al. Clonorchis sinensis ESPs enhance the activation of hepatic stellate cells by a cross-talk of TLR4 and TGF-β/Smads signaling pathway[J]. Acta Trop, 2020, 205: 105307. doi: 10.1016/j.actatropica.2019.105307

[91] Wang Y, Zhang X, Wang X, et al. Clonorchis sinensis aggravates biliary fibrosis through promoting IL-6 production via toll-like receptor 2-mediated AKT and p38 signal pathways[J]. PLoS Negl Trop Dis, 2023, 17(1): e0011062. doi: 10.1371/journal.pntd.0011062

[92] Yan C, Li B, Fan F, et al. The roles of Toll-like receptor 4 in the pathogenesis of pathogen-associated biliary fibrosis caused by Clonorchis sinensis[J]. Sci Rep, 2017, 7(1): 3909. doi: 10.1038/s41598-017-04018-8

[93] Pak JH, Bashir Q, Kim IK, et al. Clonorchis sinensis excretory-secretory products promote the migration and invasion of cholangiocarcinoma cells by activating the integrin β4-FAK/Src signaling pathway[J]. Mol Biochem Parasitol, 2017, 214: 1-9. doi: 10.1016/j.molbiopara.2017.03.002

[94] Pak JH, Shin J, Song IS, et al. Clonorchis sinensis excretory-secretory products regulate migration and invasion in cholangiocarcinoma cells via extracellular signal-regulated kinase 1/2/nuclear factor-κB-dependent matrix metalloproteinase-9 expression[J]. Int J Parasitol, 2017, 47(1): 51-59. doi: 10.1016/j.ijpara.2016.10.004

[95] Ponomarev DV, Lishai EA, Kovner AV, et al. Extracellular vesicles of the liver fluke Opisthorchis felineus stimulate the angiogenesis of human umbilical vein endothelial cells[J]. Curr Res Parasitol Vector Borne Dis, 2023, 4: 100153. doi: 10.1016/j.crpvbd.2023.100153

[96] Kovner AV, Tarasenko AA, Zaparina O, et al. Wound healing approach based on excretory-secretory product and lysate of liver flukes[J]. Sci Rep, 2022, 12(1): 21639. doi: 10.1038/s41598-022-26275-y

[97] Liu R, Meng X, Li C, et al. Trichinella spiralis cathepsin L induces macrophage M1 polarization via the NF-κB pathway and enhances the ADCC killing of newborn larvae[J]. Parasit Vectors, 2023, 16(1): 433. doi: 10.1186/s13071-023-06051-1

[98] Song YY, Zhang Y, Yang D, et al. The immune protection induced by a serine protease inhibitor from the foodborne parasite Trichinella spiralis[J]. Front Microbiol, 2018, 9: 1544. doi: 10.3389/fmicb.2018.01544

[99] Xu J, Wu L, Yu P, et al. Effect of T. spiralis Serine protease inhibitors on TNBS-induced experimental colitis mediated by Macrophages[J]. Sci Rep, 2020, 10(1): 3147. doi: 10.1038/s41598-020-60155-7

[100] Tong M, Yang X, Qiao Y, et al. Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk[J]. Biomed Pharmacother, 2024, 172: 116223. doi: 10.1016/j.biopha.2024.116223

[101] Li H, Qiu D, Yuan Y, et al. Trichinella spiralis cystatin alleviates polymicrobial sepsis through activating regulatory macrophages[J]. Int Immunopharmacol, 2022, 109: 108907. doi: 10.1016/j.intimp.2022.108907

[102] Kobpornchai P, Flynn RJ, Reamtong O, et al. A novel cystatin derived from Trichinella spiralis suppresses macrophage-mediated inflammatory responses[J]. PLoS Negl Trop Dis, 2020, 14(4): e0008192. doi: 10.1371/journal.pntd.0008192

[103] Kamata I, Yamada M, Uchikawa R, et al. Cysteine protease of the nematode Nippostrongylus brasiliensis preferentially evokes an IgE/IgG1 antibody response in rats[J]. Clin Exp Immunol, 1995, 102(1): 71-77. doi: 10.1111/j.1365-2249.1995.tb06638.x

[104] Dainichi T, Maekawa Y, Ishii K, et al. Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response[J]. Infect Immun, 2001, 69(12): 7380-7386. doi: 10.1128/IAI.69.12.7380-7386.2001

[105] Boros Z, Gherman CM, Lefkaditis M, et al. The oncogenic and oncostatic action of Trichinella spp. in animals[J]. Sci Parasitol, 2019, 20(1-2): 5-11.

[106] Du L, Tang H, Ma Z, et al. The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice[J]. Dig Dis Sci, 2011, 56(10): 2810-2817. doi: 10.1007/s10620-011-1689-8

[107] Hao C, Wang W, Zhan B, et al. Trichinella spiralis paramyosin induces colonic regulatory T cells to mitigate inflammatory bowel disease[J]. Front Cell Dev Biol, 2021, 9: 695015. doi: 10.3389/fcell.2021.695015

[108] Smallwood TB, Navarro S, Cristofori-Armstrong B, et al. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo[J]. J Biol Chem, 2021, 297(1): 100834. doi: 10.1016/j.jbc.2021.100834

[109] Zhan B, Badamchian M, Meihua B, et al. Molecular cloning and purification of Ac-TMP, a developmentally regulated putative tissue inhibitor of metalloprotease released in relative abundance by adult Ancylostoma hookworms[J]. Am J Trop Med Hyg, 2002, 66(3): 238-244. doi: 10.4269/ajtmh.2002.66.238

[110] Navarro S, Pickering DA, Ferreira IB, et al. Hookworm recombinant protein promotes regulatory T cell responses that suppress experimental asthma[J]. Sci Transl Med, 2016, 8(362): 362ra143. doi: 10.1126/scitranslmed.aaf8807

[111] Jones KM, Zhan B, Ernste KJ, et al. Immunomodulatory proteins from hookworms reduce cardiac inflammation and modulate regulatory responses in a mouse model of chronic Trypanosoma cruzi infection[J]. Front Parasitol, 2023, 2: 1244604. doi: 10.3389/fpara.2023.1244604

[112] Buitrago G, Pickering D, Ruscher R, et al. A netrin domain-containing protein secreted by the human hookworm Necator americanus protects against CD4 T cell transfer colitis[J]. Transl Res, 2021, 232: 88-102. doi: 10.1016/j.trsl.2021.02.012

[113] Langdon K, Buitrago G, Pickering D, et al. Na-AIP-1 secreted by human hookworms suppresses collagen-induced arthritis[J]. Inflammopharmacology, 2022, 30(2): 527-535. doi: 10.1007/s10787-021-00909-5

[114] Wu X, Zhang Q, Ding X, et al. Polarization of human acute monocytic leukemia THP-1 cells-derived macrophages induced by Nippostrongylus brasiliensis proteins in vitro[J]. Chin J Schisto Control, 2020, 32(4): 367-373,379. https://www.zgxfzz.com/CN/Y2020/V32/I4/367 (in Chinese)

[115] Yang Y, Ding X, Chen F, et al. Inhibition effects of Nippostrongylus brasiliensis and its derivatives against atherosclerosis in ApoE^-/- mice through anti-inflammatory response[J]. Pathogens, 2022, 11(10): 1208. doi: 10.3390/pathogens11101208

[116] Thuma N, Döhler D, Mielenz D, et al. A newly identified secreted larval antigen elicits basophil-dependent protective immunity against N. brasiliensis infection[J]. Front Immunol, 2022, 13: 979491. doi: 10.3389/fimmu.2022.979491

[117] Gao X, Yang Y, Liu X, et al. Extracellular vesicles derived from Trichinella spiralis prevent colitis by inhibiting M1 macrophage polarization[J]. Acta Trop, 2021, 213: 105761. doi: 10.1016/j.actatropica.2020.105761

[118] Yang Y, Liu L, Liu X, et al. Extracellular vesicles derived from Trichinella spiralis muscle larvae ameliorate TNBS-induced colitis in mice[J]. Front Immunol, 2020, 11: 1174. doi: 10.3389/fimmu.2020.01174

[119] Eichenberger RM, Ryan S, Jones L, et al. Hookworm secreted extracellular vesicles interact with host cells and prevent inducible colitis in mice[J]. Front Immunol, 2018, 9: 850. doi: 10.3389/fimmu.2018.00850

[120] Wang J, Tang B, You X, et al. Trichinella spiralis excretory/secretory products from adult worms inhibit NETosis and regulate the production of cytokines from neutrophils[J]. Parasit Vectors, 2023, 16(1): 374. doi: 10.1186/s13071-023-05979-8

[121] Yang Y, He Y, Yang X, et al. Effect of Trichinella spiralis-derived antigens on nonalcoholic fatty liver disease induced by high-fat diet in mice[J]. ACS Pharmacol Transl Sci, 2024, 7(2): 432-444. doi: 10.1021/acsptsci.3c00276

[122] Wang Z, Hao C, Zhuang Q, et al. Excretory/secretory products from Trichinella spiralis adult worms attenuated DSS-induced colitis in mice by driving PD-1-mediated M2 macrophage polarization[J]. Front Immunol, 2020, 11: 563784. doi: 10.3389/fimmu.2020.563784

[123] Li H, Qiu D, Yang H, et al. Therapeutic efficacy of excretory-secretory products of Trichinella spiralis adult worms on sepsis-induced acute lung injury in a mouse model[J]. Front Cell Infect Microbiol, 2021, 11: 653843. doi: 10.3389/fcimb.2021.653843

[124] Ding J, Tang B, Liu X, et al. Excretory-secretory product of Trichinella spiralis inhibits tumor cell growth by regulating the immune response and inducing apoptosis[J]. Acta Trop, 2022, 225: 106172. doi: 10.1016/j.actatropica.2021.106172

[125] Chen Y, Zhang M, Ding X, et al. Mining anti-inflammation molecules from Nippostrongylus brasiliensis-derived products through the metabolomics approach[J]. Front Cell Infect Microbiol, 2021, 11: 781132. doi: 10.3389/fcimb.2021.781132

[126] Khudhair Z, Alhallaf R, Eichenberger RM, et al. Administration of hookworm excretory/secretory proteins improves glucose tolerance in a mouse model of type 2 diabetes[J]. Biomolecules, 2022, 12(5): 637. doi: 10.3390/biom12050637

[127] Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more[J]. Nat Rev Cancer, 2016, 16(7): 431-446. doi: 10.1038/nrc.2016.52

[128] Ranasinghe SL, Fischer K, Zhang W, et al. Cloning and characterization of two potent Kunitz type protease inhibitors from Echinococcus granulosus[J]. PLoS Negl Trop Dis, 2015, 9(12): e0004268. doi: 10.1371/journal.pntd.0004268

[129] Sagasti C, Casaravilla C, Fernández C, et al. Inhibition of inflammatory cytokine production and proliferation in macrophages by Kunitz-type inhibitors from Echinococcus granulosus[J]. Mol Biochem Parasitol, 2021, 242: 111351. doi: 10.1016/j.molbiopara.2021.111351

[130] Wang H, Li J, Zhang C, et al. Echinococcus granulosus sensu stricto: silencing of thioredoxin peroxidase impairs the differentiation of protoscoleces into metacestodes[J]. Parasite, 2018, 25: 57. doi: 10.1051/parasite/2018055

[131] Wang H, Zhang C, Fang B, et al. Thioredoxin peroxidase secreted by Echinococcus granulosus (sensu stricto) promotes the alternative activation of macrophages via PI3K/AKT/mTOR pathway[J]. Parasit Vectors, 2019, 12(1): 542. doi: 10.1186/s13071-019-3786-z

[132] An X, Xiang W, Liu X, et al. A bioengineered nanovesicle vaccine boosts T-B cell interaction for immunotherapy of Echinococcus multilocularis[J]. Angew Chem Int Ed, 2024, 63(13): e202319489. doi: 10.1002/anie.202319489

[133] Nono JK, Lutz MB, Brehm K. A secreted Echinococcus multilocularis activin A homologue promotes regulatory T cell expansion[EB/OL]. [2024-05-01]. https://www.biorxiv.org/content/10.1101/618140v1.

[134] Rodríguez-Rodríguez N, Madera-Salcedo IK, Bugarin-Estrada E, et al. The helminth-derived peptide GK-1 induces an anti-tumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway[J]. Clin Immunol, 2020, 212: 108240. doi: 10.1016/j.clim.2019.07.006

[135] Jeong MJ, Kang SA, Choi JH, et al. Extracellular vesicles of Echinococcus granulosus have therapeutic effects in allergic airway inflammation[J]. Parasite Immunol, 2021, 43(10-11): e12872. doi: 10.1111/pim.12872

[136] Yang J, Wu J, Fu Y, et al. Identification of different extracellular vesicles in the hydatid fluid of Echinococcus granulosus and immunomodulatory effects of 110 K EVs on sheep PBMCs[J]. Front Immunol, 2021, 12: 602717. doi: 10.3389/fimmu.2021.602717

[137] Wu J, Cai M, Yang J, et al. Comparative analysis of different extracellular vesicles secreted by Echinococcus granulosus protoscoleces[J]. Acta Trop, 2021, 213: 105756. doi: 10.1016/j.actatropica.2020.105756

[138] Shi C, Zhou X, Yang W, et al. Proteomic analysis of plasma-derived extracellular vesicles from mice with Echinococcus granulosus at different infection stages and their immunomodulatory functions[J]. Front Cell Infect Microbiol, 2022, 12: 805010. doi: 10.3389/fcimb.2022.805010

[139] Chong S, Chen G, Dang Z, et al. Echinococcus multilocularis drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis[J]. Bioengineered, 2022, 13(4): 8747-8758. doi: 10.1080/21655979.2022.2056690

[140] Silva-Álvarez V, Folle AM, Ramos AL, et al. Echinococcus granulosus Antigen B binds to monocytes and macrophages modulating cell response to inflammation[J]. Parasit Vectors, 2016, 9: 69. doi: 10.1186/s13071-016-1350-7

[141] Wu J, Zhu Y, Zhou L, et al. Parasite-derived excretory-secretory products alleviate gut microbiota dysbiosis and improve cognitive impairment induced by a high-fat diet[J]. Front Immunol, 2021, 12: 710513. doi: 10.3389/fimmu.2021.710513

[142] Berriel E, Russo S, Monin L, et al. Antitumor activity of human hydatid cyst fluid in a murine model of colon cancer[J]. ScientificWorldJournal, 2013, 2013: 230176. doi: 10.1155/2013/230176

[143] Berriel E, Freire T, Chiale C, et al. Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1.1⁺ cell activation in mice[J]. Cancer Immunol Immunother, 2021, 70(12): 3617-3627. doi: 10.1007/s00262-021-02948-x

[144] Hou J, Li L, Dong D, et al. Glycomolecules in Echinococcus granulosus cyst fluid inhibit TLR4-mediated inflammatory responses via c-Raf[J]. Cell Mol Immunol, 2020, 17(4): 423-425. doi: 10.1038/s41423-019-0314-1

[145] Terrazas CA, Alcántara-Hernández M, Bonifaz L, et al. Helminth-excreted/secreted products are recognized by multiple receptors on DCs to block the TLR response and bias Th2 polarization in a cRAF dependent pathway[J]. FASEB J, 2013, 27(11): 4547-4560. doi: 10.1096/fj.13-228932

[146] Tundup S, Srivastava L, Harn Jr DA. Polarization of host immune responses by helminth-expressed glycans[J]. Ann N Y Acad Sci, 2012, 1253: E1-E13. doi: 10.1111/j1749-6632

[147] Callejas BE, Mendoza-Rodríguez MG, Villamar-Cruz O, et al. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulation[J]. Int J Cancer, 2019, 145(11): 3126-3139. doi: 10.1002/ijc.32626